Variables to predict engraftment of umbilical cord blood into immunodeficient mice: Usefulness of the non-obese diabetic - Severe combined immunodeficient assay

British Journal of Haematology

Volumn 114, Issue 1, 2001, Pages 211-218

  Ballen, Karen K ^a,c   Valinski, Helen ^a   Greiner, Dale ^a   Shultz, Leonard D ^b   Becker, Pamela S ^a   Hsieh, Chung Cheng ^a   Marc Stewart, F ^a   Quesenberry, Peter J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b JACKSON LABORATORY   (United States)

^c University of Massachusetts   (United States)

Author keywords

Cord blood; Immunodeficient mice; Variability

Indexed keywords

CD45 ANTIGEN;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD DONOR; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; SCID MOUSE; SEX DIFFERENCE; SURVIVAL RATE; UMBILICAL CORD BLOOD;

ANIMALS; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MODELS, ANIMAL; PREGNANCY; PROGNOSIS; RADIATION DOSAGE; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 0034933145     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02904.x     Document Type: Article

References (37)

1. Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD-scid mice
2. Bigger is better: Maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units
3. Modulation of adhesion of CD 34+ cells to extracellular matrix by expansion cytokines: Reversible adhesion defect correlates with cell cycle progression
4. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice
5. + cells
6. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice
7. Human growth factor-enhanced regeneration of transplantable human hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient mice
8. Sustained proliferation, multilineage differentiation and maintenance of primitive human haematopoietic cells in NOD-scid mice transplanted with human cord blood
9. Kinetic evidence of the regeneration of multilineage hematopiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice
10. Cord blood transplantation study (COBLT): Cord blood bank standard operating procedures
11. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling
12. Outcome of cord blood transplantation from related and unrelated donors
13. SCID mouse models of human stem cell engraftment
14. + cord blood cells
15. + enriched cells from umbilical cord blood in NOD/Ltgz-Scid mice
16. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow
17. Treatment of non-obese diabetic (NOD)/severe-combined immunodeficient mice (SCID) with flt3ligand and interleukin-7 impairs the B-lineage commitment of repopulating cells after transplantation of human hematopoietic cells
18. Hematopoietic transplant potential of unrelated cord blood: Critical issues
19. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients
20. Clinical scale isolation of highly purified peripheral CD 34+ progenitors for autologous and allogeneic transplantation in children
21. Quantity and quality of engrafting cells in cord blood and autologous mobilized peripheral blood
22. Transplantation of allogeneic CD 34 blood cells
23. Factors associated with outcome after cord blood transplantation in children with acute leukemia
24. Improved engraftment of human stem cells in NOD LtSz scid/scid mice after radiation and multiple day injections
25. CD4+cell selection from frozen cord blood products using the Isolex 300i and CliniMACS CD34 selection devices
26. Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice
27. Comparison of repopulating ability of hematopoietic progenitor cells isolated from human umbilical cord blood or bone marrow cells in NOD/SCID mice
28. Ex vivo expansion of murine marrow cells with interleukin-3, interlenkin-6, interleukin-11, and stem cell factor leads to impaired engraftment in irradiated hosts
29. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD 34+ cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells
30. The placental blood program of the Barcelona Cord Blood Bank
31. Outcomes among 562 recipients of placental blood transplants from unrelated donors
32. Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: Evidence for accessory cell involvement in expansion of immature CD 34+ CD 38- cells
33. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice
34. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay
35. Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity